Pharma - Multi Cap

Pharma - Multi Cap

by Axis Securities Ltd (ASL) Research

Multi-cap Pharma stocks,where we expect strong growth in the earnings given the lower base in the past & recovery in US business.


About the smallcase

Overall Pharma sector was under pressure in the past 2 years. However, we believe progressive improvement in business outlook, primarily driven by healthy growth in domestic business, normalization of price erosion in US business coupled with big ticket launches for selected companies, and favorable currency movement.

Live Performance

Unlock all metrics

Login to see the live performance and return

Understand smallcase costs and returns

About the Manager

People also viewed